IRIS
PEDICA, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 190
EU - Europa 162
AS - Asia 77
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 188
IT - Italia 67
CN - Cina 50
SE - Svezia 44
FI - Finlandia 16
DE - Germania 14
SG - Singapore 11
RU - Federazione Russa 10
IN - India 9
GB - Regno Unito 4
IE - Irlanda 4
CA - Canada 2
FR - Francia 2
HK - Hong Kong 2
TW - Taiwan 2
AU - Australia 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
NL - Olanda 1
TR - Turchia 1
Totale 431
Salva come PNG Salva come JPEG
Città #
Boardman 37
Shanghai 36
Milan 32
Ashburn 30
New York 18
Helsinki 13
Lawrence 12
Princeton 12
Singapore 8
Seattle 7
Rome 5
Dublin 4
Moscow 4
Baltimore 3
Cagliari 3
Lappeenranta 3
Los Angeles 3
Pune 3
Redditch 3
Trento 3
Washington 3
Brembate di Sopra 2
Cittadella 2
Hyderabad 2
Indore 2
Lucca 2
Lyon 2
Parma 2
Turin 2
Vandalia 2
Visakhapatnam 2
Yekaterinburg 2
Adapazarı 1
Assago 1
Berlin 1
Borås 1
Brisbane 1
Cambridge 1
Central 1
Civitavecchia 1
Fukushima 1
Gatchina 1
Legnano 1
London 1
Munich 1
Nizhniy Novgorod 1
Nuremberg 1
Omsk 1
Palermo 1
Pisa 1
Santa Clara 1
St Petersburg 1
Toronto 1
Winnipeg 1
Totale 286
Salva come PNG Salva come JPEG
Nome #
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 36
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 27
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 24
Pathology and molecular pathology of cholangiocarcinoma 24
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 20
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 17
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 16
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 16
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 15
HCC in metabolic syndrome: current concepts and future directions 14
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 13
Cholangiocarcinoma: new perspectives for new horizons 13
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 12
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 12
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 12
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 12
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 11
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 11
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 10
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 10
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 10
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 10
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 9
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 9
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 9
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 9
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 9
Massive retinal gliosis in a young woman with congenital toxoplasmosis 9
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 9
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 9
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 8
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 8
Endocrine neoplasms of the pancreas: pathologic and genetic features. 8
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 7
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 7
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 6
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 6
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 6
Laparoscopic surgery for intrahepatic cholangiocarcinoma: A focus on oncological outcomes 6
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 5
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 5
Association of IgG4-related disease and systemic rheumatic disorders 5
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 5
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 5
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 4
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 4
IgG4-related autoimmune liver disease 4
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 4
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 4
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 4
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 3
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 3
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 3
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 3
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 2
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 2
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 2
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 2
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 2
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 2
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 2
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 1
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 1
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 1
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 1
Clinicopathological features of adenosquamous pancreatic cancer 1
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 1
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 1
Paraoxonase-1 status in patients with hereditary hemochromatosis 1
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 1
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 1
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 1
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 1
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 1
Totale 567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 5 0 0 0 0 0
2020/20212 0 0 0 0 1 0 1 0 0 0 0 0
2021/202215 0 0 2 3 0 2 2 2 1 2 0 1
2022/202385 27 17 9 0 1 15 5 4 7 0 0 0
2023/2024450 11 65 50 41 20 33 19 42 4 18 64 83
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 567